Yee, L. M., Miller, E. C. & Greenland, P. Mitigating the Long-term Health Risks of Adverse Pregnancy Outcomes. JAMA 327, 421–422. https://doi.org/10.1001/jama.2021.23870 (2022).
Yu, J. et al. Burden of female infertility in China from 1990 to 2019: a temporal trend analysis and forecasting, and comparison with the global level. Sex Health 20, 577–584. https://doi.org/10.1071/SH23029 (2023).
Wang, Y., Wang, W., Li, H. & Du, Q. Trends in the burden of female infertility among adults aged 20–49 years during 1990–2019: an analysis of data from the Global Burden of Disease Study 2019. BMJ Open 14, e084755. https://doi.org/10.1136/bmjopen-2024-084755 (2024).
Mielczarek, E. & Blaszkowska, J. Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure. Infection 44, 447–458. https://doi.org/10.1007/s15010-015-0860-0 (2016).
Zheng, X. et al. Host Genetic Risk Factors for Chlamydia trachomatis-Related Infertility in Women. J Infect Dis 224, S64–S71. https://doi.org/10.1093/infdis/jiab149 (2021).
Human immunodeficiency virus and infertility treatment. Fertil Steril 94, 11–15. https://doi.org/10.1016/j.fertnstert.2010.01.077 (2010).
Tsevat, D. G., Wiesenfeld, H. C., Parks, C. & Peipert, J. F. Sexually transmitted diseases and infertility. Am J Obstet Gynecol 216, 1–9. https://doi.org/10.1016/j.ajog.2016.08.008 (2017).
Morsli, M. et al. The association between lifestyle factors and the composition of the vaginal microbiota: a review. Eur J Clin Microbiol Infect Dis 43, 1869–1881. https://doi.org/10.1007/s10096-024-04915-7 (2024).
Van Gerwen, O. T., Muzny, C. A. & Marrazzo, J. M. Sexually transmitted infections and female reproductive health. Nat Microbiol 7, 1116–1126. https://doi.org/10.1038/s41564-022-01177-x (2022).
Bogaert, K. et al. Gynecologic care utilization in asylum-seeking women in New York City. J Migr Health 6, 100116. https://doi.org/10.1016/j.jmh.2022.100116 (2022).
Motrico, E., Galán-Luque, T., Rodríguez-Domínguez, C., Gómez-Gómez, I. & Domínguez-Salas, S. Factors Associated with Post-Traumatic Stress Symptoms in Pregnant and Postpartum Women. J Womens Health (Larchmt) 32, 583–591. https://doi.org/10.1089/jwh.2022.0400 (2023).
Unemo, M. et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis 17, e235–e279. https://doi.org/10.1016/S1473-3099(17)30310-9 (2017).
Gottlieb, S. L. et al. WHO global research priorities for sexually transmitted infections. The Lancet Global Health 12, e1544–e1551. https://doi.org/10.1016/S2214-109X(24)00266-3 (2024).
Lago, E. G., Vaccari, A. & Fiori, R. M. Clinical features and follow-up of congenital syphilis. Sex Transm Dis 40, 85–94. https://doi.org/10.1097/OLQ.0b013e31827bd688 (2013).
Reimche, J. L. et al. Genomic analysis of 1710 surveillance-based Neisseria gonorrhoeae isolates from the USA in 2019 identifies predominant strain types and chromosomal antimicrobial-resistance determinants. Microb Genom 9 (2023). https://doi.org/10.1099/mgen.0.001006
Role of tubal surgery in the era of assisted reproductive technology: a committee opinion. Fertil Steril 115, 1143–1150 (2021). https://doi.org/10.1016/j.fertnstert.2021.01.051
Carson, S. A. & Kallen, A. N. Diagnosis and Management of Infertility: A Review. JAMA 326, 65–76. https://doi.org/10.1001/jama.2021.4788 (2021).
Davies, B. et al. Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. Lancet Infect Dis 16, 1057–1064. https://doi.org/10.1016/S1473-3099(16)30092-5 (2016).
Reekie, J. et al. Risk of Pelvic Inflammatory Disease in Relation to Chlamydia and Gonorrhea Testing, Repeat Testing, and Positivity: A Population-Based Cohort Study. Clin Infect Dis 66, 437–443. https://doi.org/10.1093/cid/cix769 (2018).
Guaschino, S. & De Seta, F. Update on Chlamydia trachomatis. Ann N Y Acad Sci 900, 293–300 (2000).
Weström, L., Joesoef, R., Reynolds, G., Hagdu, A. & Thompson, S. E. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 19, 185–192 (1992).
Dare, F. O., Bako, A. U. & Ezechi, O. C. Puerperal sepsis: a preventable post-partum complication. Trop Doct 28, 92–95 (1998).
Hussein, J. & Walker, L. Puerperal sepsis in low and middle income settings: past, present and future. Maternal and infant deaths: chasing millennium development goals 4, 131–147 (2010).
Linhares, I. M. & Witkin, S. S. Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract. Cell Stress Chaperones 15, 467–473. https://doi.org/10.1007/s12192-010-0171-4 (2010).
Clausen, H. F. et al. Serological investigation of Mycoplasma genitalium in infertile women. Hum Reprod 16, 1866–1874 (2001).
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2133–2161 (2024). https://doi.org/10.1016/S0140-6736(24)00757-8
Global age-sex-specific fertility. mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1160–1203. https://doi.org/10.1016/S0140-6736(20)30977-6 (2020).
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390, 1151–1210 (2017). https://doi.org/10.1016/S0140-6736(17)32152-9
Sun, P. et al. Global, regional, and national burden of female cancers in women of child-bearing age, 1990–2021: analysis of data from the global burden of disease study 2021. EClinicalMedicine 74, 102713. https://doi.org/10.1016/j.eclinm.2024.102713 (2024).
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 402, 203–234 (2023). https://doi.org/10.1016/S0140-6736(23)01301-6
Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 395, 200–211. https://doi.org/10.1016/S0140-6736(19)32989-7 (2020).
Cannon, C. A., McLaughlin, S. E. & Ramchandani, M. S. On The Horizon: Novel Approaches to Sexually Transmitted Infection Prevention. Med Clin North Am 108, 403–418. https://doi.org/10.1016/j.mcna.2023.10.003 (2024).
Organization, W. H. Statement on maternal sepsis. (World Health Organization, 2017).
Stephens, A. J., Chauhan, S. P., Barton, J. R. & Sibai, B. M. Maternal Sepsis: A Review of National and International Guidelines. Am J Perinatol 40, 718–730. https://doi.org/10.1055/s-0041-1736382 (2023).
Fu, L. et al. Incidence Trends of Five Common Sexually Transmitted Infections Excluding HIV From 1990 to 2019 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2019. Front Med (Lausanne) 9, 851635 (2022). https://doi.org/10.3389/fmed.2022.851635
van den Broek, I. V. et al. Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey. Eur J Public Health 26, 382–388. https://doi.org/10.1093/eurpub/ckv196 (2016).
Mascarenhas, M. N., Flaxman, S. R., Boerma, T., Vanderpoel, S. & Stevens, G. A. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med 9, e1001356. https://doi.org/10.1371/journal.pmed.1001356 (2012).
Kenny, L. C. et al. Advanced maternal age and adverse pregnancy outcome: evidence from a large contemporary cohort. PLoS One 8, e56583. https://doi.org/10.1371/journal.pone.0056583 (2013).
Unemo, M., Del Rio, C. & Shafer, W. M. Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century. Microbiol Spectr 4 (2016). https://doi.org/10.1128/microbiolspec.EI10-0009-2015
Młynarczyk-Bonikowska, B., Majewska, A., Malejczyk, M., Młynarczyk, G. & Majewski, S. Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century. Med Microbiol Immunol 209 (2020). https://doi.org/10.1007/s00430-019-00651-4
Unemo, M. Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 15, 364. https://doi.org/10.1186/s12879-015-1029-2 (2015).
Unemo, M. & Nicholas, R. A. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol 7, 1401–1422. https://doi.org/10.2217/fmb.12.117 (2012).
Gottlieb, S. L. & Johnston, C. Future prospects for new vaccines against sexually transmitted infections. Curr Opin Infect Dis 30, 77–86. https://doi.org/10.1097/QCO.0000000000000343 (2017).
Manavi, K. A review on infection with Chlamydia trachomatis. Best Pract Res Clin Obstet Gynaecol 20, 941–951 (2006).
Steiner, A. Z. et al. Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes. Fertil Steril 104, 1522–1526. https://doi.org/10.1016/j.fertnstert.2015.08.022 (2015).
Smolarczyk, K. et al. The Impact of Selected Bacterial Sexually Transmitted Diseases on Pregnancy and Female Fertility. Int J Mol Sci 22 (2021). https://doi.org/10.3390/ijms22042170
Kortekaas, J. C. et al. Risk of adverse pregnancy outcomes of late- and postterm pregnancies in advanced maternal age: A national cohort study. Acta Obstet Gynecol Scand 99, 1022–1030. https://doi.org/10.1111/aogs.13828 (2020).
Seshadri, S., Morris, G., Serhal, P. & Saab, W. Assisted conception in women of advanced maternal age. Best Pract Res Clin Obstet Gynaecol 70, 10–20. https://doi.org/10.1016/j.bpobgyn.2020.06.012 (2021).
Torres, T. S. et al. Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter study. Lancet Reg Health Am 28, 100642. https://doi.org/10.1016/j.lana.2023.100642 (2023).
Bilal, U. et al. Inequalities in life expectancy in six large Latin American cities from the SALURBAL study: an ecological analysis. Lancet Planet Health 3, e503–e510. https://doi.org/10.1016/S2542-5196(19)30235-9 (2019).
Workowski, K. A. & Bolan, G. A. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64 (2015).
Kenyon, C., Herrmann, B., Hughes, G. & de Vries, H. J. C. Management of asymptomatic sexually transmitted infections in Europe: towards a differentiated, evidence-based approach. Lancet Reg Health Eur 34, 100743. https://doi.org/10.1016/j.lanepe.2023.100743 (2023).
Adachi, K., Nielsen-Saines, K. & Klausner, J. D. Chlamydia trachomatis Infection in Pregnancy: The Global Challenge of Preventing Adverse Pregnancy and Infant Outcomes in Sub-Saharan Africa and Asia. Biomed Res Int 2016, 9315757. https://doi.org/10.1155/2016/9315757 (2016).
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1545–1602 (2016). https://doi.org/10.1016/S0140-6736(16)31678-6
Medline, A., Joseph Davey, D. & Klausner, J. D. Lost opportunity to save newborn lives: variable national antenatal screening policies for Neisseria gonorrhoeae and Chlamydia trachomatis. Int J STD AIDS 28, 660–666 (2017). https://doi.org/10.1177/0956462416660483
Westrom, L. V. Chlamydia and its effect on reproduction. J Br Fer Soc 1, 23–30 (1996).
Knowles, S. J., O’Sullivan, N. P., Meenan, A. M., Hanniffy, R. & Robson, M. Maternal sepsis incidence, aetiology and outcome for mother and fetus: a prospective study. BJOG 122, 663–671. https://doi.org/10.1111/1471-0528.12892 (2015).
Giouleka, S. et al. Sepsis in Pregnancy and the Puerperium: A Comparative Review of Major Guidelines. Obstet Gynecol Surv 78, 237–248. https://doi.org/10.1097/OGX.0000000000001108 (2023).
Shields, A., de Assis, V. & Halscott, T. Top 10 Pearls for the Recognition, Evaluation, and Management of Maternal Sepsis. Obstet Gynecol 138, 289–304. https://doi.org/10.1097/AOG.0000000000004471 (2021).
Chen, L. et al. The global burden and trends of maternal sepsis and other maternal infections in 204 countries and territories from 1990 to 2019. BMC Infect Dis 21, 1074. https://doi.org/10.1186/s12879-021-06779-0 (2021).
World Health, O. WHO global surveillance and monitoring system for substandard and falsified medical products. 64 p. (World Health Organization, 2017).
Jarolimova, J. et al. Curable sexually transmitted infections among women with HIV in sub-Saharan Africa. AIDS 36, 697–709. https://doi.org/10.1097/QAD.0000000000003163 (2022).
Chico, R. M. et al. Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review. JAMA 307, 2079–2086. https://doi.org/10.1001/jama.2012.3428 (2012).
LeFevre, A. E. et al. Validation of community health worker identification of maternal puerperal sepsis using a clinical diagnostic algorithm in Bangladesh and Pakistan. J Glob Health 11, 04039. https://doi.org/10.7189/jogh.11.04039 (2021).
Evans, L. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med 49, e1063–e1143. https://doi.org/10.1097/CCM.0000000000005337 (2021).
Filetici, N., Van de Velde, M., Roofthooft, E. & Devroe, S. Maternal sepsis. Best Pract Res Clin Anaesthesiol 36, 165–177. https://doi.org/10.1016/j.bpa.2022.03.003 (2022).
Otu, A. et al. How to close the maternal and neonatal sepsis gap in sub-Saharan Africa. BMJ Glob Health 5, e002348. https://doi.org/10.1136/bmjgh-2020-002348 (2020).
World Health, O. Infertility prevalence estimates: 1990–2021. xiv, 79 p. (World Health Organization, 2023).
World Health, O. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. v, 125 p. (World Health Organization, 2022).
World Health & O,. Global health sector strategy on sexually transmitted infections 2016–2021: toward ending STIs (World Health Organization, 2016).
Hong, Y., Fang, X., Zhou, Y., Zhao, R. & Li, X. Factors associated with sexually transmitted infection underreporting among female sex workers in China. J Womens Health (Larchmt) 20, 129–136. https://doi.org/10.1089/jwh.2010.2139 (2011).
Rao, N. et al. Infertility and self-rated health among Malawian women. Women Health 58, 1081–1093. https://doi.org/10.1080/03630242.2017.1414098 (2018).
Rouchou, B. Consequences of infertility in developing countries. Perspect Public Health 133, 174–179. https://doi.org/10.1177/1757913912472415 (2013).
Yuan, S., Qiu, Y., Xu, Y. & Wang, H. Human papillomavirus infection and female infertility: a systematic review and meta-analysis. Reprod Biomed Online 40, 229–237. https://doi.org/10.1016/j.rbmo.2019.10.019 (2020).
Gogineni, V. et al. The future of STI screening and treatment for youth: a National Survey of youth perspectives and intentions. BMC Public Health 21, 2006. https://doi.org/10.1186/s12889-021-12091-y (2021).
Evans, R. et al. Association of Sexual Health Interventions With Sexual Health Outcomes in Black Adolescents: A Systematic Review and Meta-analysis. JAMA Pediatr 174, 676–689. https://doi.org/10.1001/jamapediatrics.2020.0382 (2020).
Lopez, L. M., Bernholc, A., Chen, M. & Tolley, E. E. School-based interventions for improving contraceptive use in adolescents. Cochrane Database Syst Rev 2016, CD012249 (2016). https://doi.org/10.1002/14651858.CD012249
de Vries, A., den Daas, C., Willemstein, I. J. M., de Wit, J. B. F. & Heijne, J. C. M. Interventions Promoting Condom Use Among Youth: A Systematic Review. J Adolesc Health 74, 644–656. https://doi.org/10.1016/j.jadohealth.2023.11.014 (2024).
Whittaker, A., Gerrits, T., Hammarberg, K. & Manderson, L. Access to assisted reproductive technologies in sub-Saharan Africa: fertility professionals’ views. Sex Reprod Health Matters 32, 2355790. https://doi.org/10.1080/26410397.2024.2355790 (2024).
Wang, R. et al. Human papillomavirus vaccine against cervical cancer: Opportunity and challenge. Cancer Lett 471 (2020). https://doi.org/10.1016/j.canlet.2019.11.039
Ruiz García, Y. et al. Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect. NPJ Vaccines 6, 130. https://doi.org/10.1038/s41541-021-00388- (2021).
